NATCO PHARMA
Back to Cashflow Statement
|
NATCO PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-211 Cr | ₹-247 Cr | ₹-363 Cr | ₹35 Cr | ₹-186 Cr |
What is the latest Cash Flow from Financing Activities ratio of NATCO PHARMA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-211 Cr |
| Mar2024 | ₹-247 Cr |
| Mar2023 | ₹-363 Cr |
| Mar2022 | ₹35 Cr |
| Mar2021 | ₹-186 Cr |
How is Cash Flow from Financing Activities of NATCO PHARMA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-211 Cr | Negative | |
| Mar2024 | ₹-247 Cr | Negative | |
| Mar2023 | ₹-363 Cr | Negative | |
| Mar2022 | ₹35 Cr | Positive | |
| Mar2021 | ₹-186 Cr | - | |
Compare Cash Flow from Financing Activities of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹16,474.5 Cr | -0.8% | -1.5% | -6.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹477,312.0 Cr | 0.8% | 6.3% | 18.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹213,879.0 Cr | 8.6% | 20.7% | 18.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹194,094.0 Cr | 1.7% | 9.4% | 38.5% | Stock Analytics | |
| CIPLA | ₹118,992.0 Cr | 4.5% | 1.2% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,787.4 Cr | -0.3% | -14.8% | -9.5% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | -0.8% |
-1.5% |
-6.7% |
| SENSEX | 2.7% |
1.5% |
-5.6% |
You may also like the below Video Courses